中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/30217
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 29490/55136 (53%)
造访人次 : 1512576      在线人数 : 373
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CMUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/30217


    题名: DNA fragmentation, mitochondrial dysfunction and chromosomal aneuploidy in the spermatozoa of oligoasthenoteratozoospermic males
    作者: Liu, CH;Tsao, HM;Cheng, TC;Wu, HM;Huang, CC;Chen, CI;Lin, DPC;Lee, MS
    贡献者: 醫學院醫學系;Lee Womens Hosp, Infertil Clin Div, Taichung 406, Taiwan;Chung Shan Med Univ, Inst Med, Taichung, Taiwan;Chung Shan Med Univ, Inst Biochem, Taichung, Taiwan;China Med Coll Sch Med, Taichung, Taiwan
    日期: 2004
    上传时间: 2010-09-24 14:51:18 (UTC+8)
    出版者: KLUWER ACADEMIC/PLENUM PUBL
    摘要: Cardiac complications caused by iron deposition are major causes of death in patients with beta-thalassemia major. Deferiprone (L1) was found to have greater efficacy at depleting myocardial iron than desferrioxamine (DFX). Furthermore, combined therapy with L1 and DFX produced an additive or synergistic iron chelating effect. We report the successful treatment of severe heart failure in two patients with beta-thalassemia major with the combined therapy. Magnetic resonance images showed a marked recovery of signal intensity in the heart, indicating a significant reduction of iron load in the heart. No significant adverse effects were noted. Therefore, combined therapy with L1 and DFX should be considered in patients with beta-thalassemia major and cardiac complications.
    關聯: JOURNAL OF ASSISTED REPRODUCTION AND GENETICS 21(4):119-126
    显示于类别:[醫學系] 期刊論文

    文件中的档案:

    没有与此文件相关的档案.



    在CMUR中所有的数据项都受到原著作权保护.

    TAIR相关文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈